MACK-CALI REALTY CORP (CLI) Fundamental Analysis & Valuation

NYSE:CLI

Current stock price

18.35
-0.04 (-0.22%)
At close:
18.35
0 (0%)
After Hours:

This CLI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CLI Profitability Analysis

1.1 Basic Checks

  • In the past year CLI has reported negative net income.
CLI Yearly Net Income VS EBIT VS OCF VS FCFCLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 -200M -400M -600M -800M -1B

1.2 Ratios

Industry RankSector Rank
ROA -0.6%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLI Yearly ROA, ROE, ROICCLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 2 -2 4 6

1.3 Margins

Industry RankSector Rank
OM 1.69%
PM (TTM) -8.44%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLI Yearly Profit, Operating, Gross MarginsCLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 20 40

0

2. CLI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CLI remains at a similar level compared to 1 year ago.
  • CLI has a worse debt/assets ratio than last year.
CLI Yearly Shares OutstandingCLI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 20M 40M 60M 80M
CLI Yearly Total Debt VS Total AssetsCLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 1B 2B 3B 4B 5B

2.2 Solvency

  • CLI has a Debt/Equity ratio of 1.82. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CLI Yearly LT Debt VS Equity VS FCFCLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 1B -1B 2B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. CLI Growth Analysis

3.1 Past

  • CLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.65%, which is quite impressive.
  • Looking at the last year, CLI shows a decrease in Revenue. The Revenue has decreased by -1.41% in the last year.
  • The Revenue for CLI have been decreasing by -12.02% on average. This is quite bad
EPS 1Y (TTM)81.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
Revenue 1Y (TTM)-1.41%
Revenue growth 3Y-11.92%
Revenue growth 5Y-12.02%
Sales Q2Q%7.78%

3.2 Future

  • CLI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.95% yearly.
  • CLI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.79% yearly.
EPS Next Y-65.7%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
EPS Next 5Y0.95%
Revenue Next Year-3.9%
Revenue Next 2Y-1.99%
Revenue Next 3Y3.38%
Revenue Next 5Y4.79%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLI Yearly Revenue VS EstimatesCLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
CLI Yearly EPS VS EstimatesCLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 -2 -3

0

4. CLI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLI. In the last year negative earnings were reported.
  • Also next year CLI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLI Price Earnings VS Forward Price EarningsCLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.15
CLI Per share dataCLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLI's earnings are expected to grow with 16.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.87%
EPS Next 3Y16.13%

3

5. CLI Dividend Analysis

5.1 Amount

  • CLI has a Yearly Dividend Yield of 3.24%.
  • Compared to an average S&P500 Dividend Yield of 1.89, CLI pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

  • The dividend of CLI decreases each year by -5.01%.
  • CLI has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-5.01%
Div Incr YearsN/A
Div Non Decr YearsN/A
CLI Yearly Dividends per shareCLI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 0.2 0.4 0.6

5.3 Sustainability

  • 69.62% of the earnings are spent on dividend by CLI. This is not a sustainable payout ratio.
DP69.62%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
CLI Yearly Income VS Free CF VS DividendCLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 0 -200M -400M -600M -800M -1B
CLI Dividend Payout.CLI Dividend Payout, showing the Payout Ratio.CLI Dividend Payout.PayoutRetained Earnings

CLI Fundamentals: All Metrics, Ratios and Statistics

MACK-CALI REALTY CORP

NYSE:CLI (12/9/2021, 8:16:41 PM)

After market: 18.35 0 (0%)

18.35

-0.04 (-0.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners93.33%
Inst Owner Change-2.04%
Ins Owners2.19%
Ins Owner Change0%
Market Cap1.67B
Revenue(TTM)322.29M
Net Income(TTM)-27.19M
Analysts51.43
Price Target19.72 (7.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend0.6
Dividend Growth(5Y)-5.01%
DP69.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.18
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB N/A
EV/EBITDA 34.15
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.54
BVpS14.38
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.69%
PM (TTM) -8.44%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
EPS Next Y-65.7%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
EPS Next 5Y0.95%
Revenue 1Y (TTM)-1.41%
Revenue growth 3Y-11.92%
Revenue growth 5Y-12.02%
Sales Q2Q%7.78%
Revenue Next Year-3.9%
Revenue Next 2Y-1.99%
Revenue Next 3Y3.38%
Revenue Next 5Y4.79%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MACK-CALI REALTY CORP / CLI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MACK-CALI REALTY CORP (CLI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLI.


What is the valuation status of MACK-CALI REALTY CORP (CLI) stock?

ChartMill assigns a valuation rating of 3 / 10 to MACK-CALI REALTY CORP (CLI). This can be considered as Overvalued.


How profitable is MACK-CALI REALTY CORP (CLI) stock?

MACK-CALI REALTY CORP (CLI) has a profitability rating of 1 / 10.


What is the earnings growth outlook for MACK-CALI REALTY CORP?

The Earnings per Share (EPS) of MACK-CALI REALTY CORP (CLI) is expected to decline by -65.7% in the next year.